| Literature DB >> 3359993 |
A Muñoz1, M Zenke, U Gehring, J Sap, H Beug, B Vennström.
Abstract
To identify and characterize the hormone-binding domain of the thyroid hormone receptor, we analyzed the ligand-binding capacities of proteins representing chimeras between the normal receptor and P75gag-v-erbA, the retrovirus-encoded form deficient in binding ligand. Our results show that several mutations present in the carboxy-terminal half of P75gag-v-erbA co-operate in abolishing hormone binding, and that the ligand-binding domain resides in a position analogous to that of steroid receptors. Furthermore, a point mutation that is located between the putative DNA and ligand-binding domains of P75gag-v-erbA and that renders it biologically inactive fails to affect hormone binding by the c-erbA protein. These results suggest that the mutation changed the ability of P75gag-v-erbA to affect transcription since it also had no effect on DNA binding. Our data also suggest that hormone-independent activity of P75gag-v-erbA provided a selective advantage to the avian erythroblastosis virus during the original selection for a highly oncogenic strain of the virus.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3359993 PMCID: PMC454236 DOI: 10.1002/j.1460-2075.1988.tb02795.x
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598